Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1497-17-2

Post Buying Request

1497-17-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1497-17-2 Usage

Chemical Properties

Off-White Solid

Uses

Different sources of media describe the Uses of 1497-17-2 differently. You can refer to the following data:
1. A metabolite of calcium channel succinimide antiepileptic drug Methsuximide. Anticonvulsant.
2. A labelled metabolite of calcium channel succinimide antiepileptic drug Methsuximide.
3. A metabolite of calcium channel succinimide antiepileptic drug Methsuximide.

Check Digit Verification of cas no

The CAS Registry Mumber 1497-17-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,9 and 7 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1497-17:
(6*1)+(5*4)+(4*9)+(3*7)+(2*1)+(1*7)=92
92 % 10 = 2
So 1497-17-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H11NO2/c1-11(7-9(13)12-10(11)14)8-5-3-2-4-6-8/h2-6H,7H2,1H3,(H,12,13,14)

1497-17-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H51038)  2-Methyl-2-phenylsuccinimide, 99%   

  • 1497-17-2

  • 1g

  • 1098.0CNY

  • Detail
  • Alfa Aesar

  • (H51038)  2-Methyl-2-phenylsuccinimide, 99%   

  • 1497-17-2

  • 5g

  • 4505.0CNY

  • Detail
  • Aldrich

  • (860581)  α-Methyl-α-phenylsuccinimide  99%

  • 1497-17-2

  • 860581-1G

  • 1,453.14CNY

  • Detail

1497-17-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name α-METHYL-α-PHENYLSUCCINIMIDE

1.2 Other means of identification

Product number -
Other names 3-Phenyl-3-methylpyrrolidine-2,5-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1497-17-2 SDS

1497-17-2Relevant articles and documents

Cu-catalyzed oxygenation of alkene-tethered amides with O2: Via unactivated CC bond cleavage: A direct approach to cyclic imides

Li, Junhua,Wei, Jialiang,Zhu, Bencong,Wang, Teng,Jiao, Ning

, p. 9099 - 9103 (2019)

The transformations of unactivated alkenes through CC bond double cleavage are always attractive but very challenging. We report herein a chemoselective approach to valuable cyclic imides by a novel Cu-catalyzed geminal amino-oxygenation of unactivated CC bonds. O2 was successfully employed as the oxidant as well as the O-source and was incorporated into alkenyl amides via CC bond cleavage for the efficient preparation of succinimide or glutarimide derivatives. Moreover, the present strategy under simple conditions can be used in the late-stage modification of biologically active compounds and the synthesis of pharmaceuticals, which demonstrated the potential application.

Synthesis and anticonvulsant properties of new mannich bases derived from 3,3-disubstituted pyrrolidine-2,5-diones. Part IV

Obniska, Jolanta,Chlebek, Iwona,Kaminski, Krzysztof

, p. 713 - 722 (2012/10/30)

A library of 21 new N-Mannich bases of 3,3-diphenyl- (5a-g), 3-methyl-3-phenyl- (6a-g), and 3-ethyl-3-methylpyrrolidine-2,5-diones (7a-g) were synthesized and evaluated for their anticonvulsant activity in the maximum electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) seizure tests after intraperitoneal injection into mice. The acute neurological toxicity was determined applying the rotarod screen. The results in mice showed that 13 compounds were effective in the MES or/and scPTZ screen. From these, seven molecules were tested in the MES seizures after oral administration in rats. The quantitative studies showed that N-[{4-(2-hydroxyethyl)-piperazin-1-yl}-methyl] -3-methyl-3-phenylpyrrolidine-2,5-dione (6c) and N-[(4-benzylpiperidin-1-yl)- methyl]-3-methyl-3-phenylpyrrolidine-2,5-dione (6f) revealed higher protection in the MES and scPTZ tests than valproic acid or ethosuximide which were used as reference antiepileptic drugs. Four compounds (5c, 6c, 6e, 6f) showed high effectiveness in the 6-Hz psychomotor seizure model of partial and therapy resistant epilepsy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1497-17-2